Lataa...
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry
BACKGROUND: PYRAMID was an international multicenter, noninterventional, postmarketing registry assessing long-term safety and effectiveness of adalimumab (Humira), as used in routine clinical practice. METHODS: Adult patients with moderately to severely active Crohn’s disease with or without prior...
Tallennettuna:
| Julkaisussa: | Inflamm Bowel Dis |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6701510/ https://ncbi.nlm.nih.gov/pubmed/30753510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izz008 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|